We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
10 Year Est. Return
AUM
$13.7B
AUM Growth
+$1.01B
Cap. Flow
+$589M
Cap. Flow %
4.3%
Top 10 Hldgs %
11.63%
Holding
1,581
New
640
Increased
361
Reduced
263
Closed
311

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$90.4M
2
PFE icon
Pfizer
PFE
+$82.7M
3
MCD icon
McDonald's
MCD
+$65.4M
4
KDP icon
Keurig Dr Pepper
KDP
+$64.6M
5
ULTA icon
Ulta Beauty
ULTA
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.96%
2 Technology 16.17%
3 Consumer Discretionary 15.54%
4 Industrials 10.23%
5 Financials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENBL
951
DELISTED
ENABLE MIDSTREAM PARTNERS, LP
ENBL
$936K 0.01%
+58,489
New +$931K
HALO icon
952
Halozyme
HALO
$9.92B
$935K 0.01%
71,929
+4,220
+6% +$56.4K
DPLO
953
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$935K 0.01%
+62,324
New +$1.04M
ALGT icon
954
Allegiant Air
ALGT
$2.86B
$919K 0.01%
+6,757
New +$990K
HTGC icon
955
Hercules Capital
HTGC
$3.11B
$916K 0.01%
+70,464
New +$979K
RRGB icon
956
Red Robin
RRGB
$150M
$911K 0.01%
+14,014
New +$889K
SXCP
957
DELISTED
SunCoke Energy Partners, L.P.
SXCP
$910K 0.01%
+50,576
New +$843K
EXAS
958
DELISTED
Exact Sciences
EXAS
$908K 0.01%
25,936
-163,926
-86% -$5.06M
SHPG
959
DELISTED
Shire pic
SHPG
$905K 0.01%
5,484
-14,716
-73% -$2.57M
ACGL icon
960
Arch Capital
ACGL
$33.7B
$904K 0.01%
29,172
+13,377
+85% +$424K
CPB icon
961
Campbell Soup
CPB
$6.78B
$900K 0.01%
17,310
-32,898
-66% -$1.86M
NVRO
962
DELISTED
NEVRO CORP.
NVRO
$891K 0.01%
12,046
+6,958
+137% +$557K
SKM icon
963
SK Telecom
SKM
$13.4B
$883K 0.01%
+20,615
New +$827K
PENN icon
964
PENN Entertainment
PENN
$2.67B
$879K 0.01%
41,854
-1,193,076
-97% -$23.5M
SMC
965
Summit Midstream
SMC
$428M
$879K 0.01%
+2,548
New +$886K
LW icon
966
Lamb Weston
LW
$7.33B
$876K 0.01%
19,927
-79,621
-80% -$3.5M
ELV icon
967
Elevance Health
ELV
$83.8B
$875K 0.01%
+4,656
New +$837K
TRTN
968
DELISTED
Triton International Limited
TRTN
$874K 0.01%
+26,470
New +$782K
ELGX
969
DELISTED
Endologix Inc
ELGX
$870K 0.01%
17,394
+12,784
+277% +$753K
ALRM icon
970
Alarm.com
ALRM
$2.76B
$868K 0.01%
22,850
-160,809
-88% -$5.39M
EVHC
971
DELISTED
Envision Healthcare Holdings Inc
EVHC
$868K 0.01%
13,773
-153,609
-92% -$8.85M
GTS
972
DELISTED
Triple-S Management Corporation
GTS
$864K 0.01%
53,428
+2,572
+5% +$42.2K
MGNI icon
973
Magnite
MGNI
$2.97B
$863K 0.01%
+172,535
New +$948K
SRI icon
974
Stoneridge
SRI
$211M
$863K 0.01%
57,523
+14,606
+34% +$245K
CQP icon
975
Cheniere Energy
CQP
$31.2B
$862K 0.01%
+26,946
New +$860K

Similar funds

Marshall Wace North America's Q2 2017 Portfolio in Review

As of Q2 2017, Marshall Wace North America held 1,581 positions worth $13.7B, up 8% from $12.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace North America deployed $589M of net new capital in Q2 2017, opening 640 new positions and adding to 361 existing holdings. Its largest new stake was Ulta Beauty: 218,927 shares worth $62.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was T-Mobile US, an estimated $225M trimmed.

  • Marshall Wace North America's largest Q2 2017 buy was Ulta Beauty: 218,927 shares worth $62.8M.
  • Marshall Wace North America added most to Alphabet (Google) Class A in Q2 2017, an estimated $90.4M increase.
  • Marshall Wace North America's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $225M.
  • Marshall Wace North America fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $120M.
  • Marshall Wace North America's ten largest holdings make up 12% of its $13.7B portfolio in Q2 2017.
  • Marshall Wace North America opened 640 new positions and closed 311 in Q2 2017.
  • Marshall Wace North America's portfolio value rose 8% quarter-over-quarter to $13.7B.

Based on Marshall Wace North America's 13F filing for Q2 2017, filed 4 Aug 2017.